Literature DB >> 25399404

Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients?

Tamara O Thomas1, John L Jefferies, Angela Lorts, Jeffrey B Anderson, Zhiqian Gao, D Woodrow Benson, Kan N Hor, Linda H Cripe, Elaine M Urbina.   

Abstract

Cardiac manifestations of Duchenne muscular dystrophy (DMD) include progressive cardiac dysfunction and an elevated resting heart rate (HR). We hypothesized this elevated HR reflects autonomic dysfunction that can be identified by heart rate variability (HRV) analyses which will be associated with myocardial fibrosis by cardiac magnetic resonance imaging (cMR). DMD patients (N = 74) and controls (N = 17) had time and frequency domain HRV analyses calculated via Holter monitoring. Cardiac magnetic resonance imaging was performed on DMD cases only. χ (2) test, T test, ANOVA, and logistic regression were used to perform comparisons between groups. A p value of <0.05 was used for statistical significance. DMD cases had higher resting average HR than controls (99.4 ± 8.9, 85.4 + 6.2, p < 0.001). Among HRV variables, decreases were seen in the following: standard deviation of R to R intervals, the percent RR intervals differing by >50 ms from previous RR interval, the root-meansquare of successive differences of RR intervals, the standard deviation of the mean R to R segment (SDANN), low frequency, and high frequency domain, all p values 0.001. Maximum HR and SDANN most significantly associated with positive LGE on cMR (p = 0.008, p = 0.016). DMD cases on beta blocker had an average HR lower than those not on beta blocker (p = 0.009), but with no difference in HRV analysis. DMD patients have reduced HRV and therefore autonomic dysfunction prior to the onset of heart failure which is associated with myocardial fibrosis.

Entities:  

Mesh:

Year:  2014        PMID: 25399404     DOI: 10.1007/s00246-014-1050-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  22 in total

1.  Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy.

Authors:  B J Boland; P L Silbert; R V Groover; P C Wollan; M D Silverstein
Journal:  Pediatr Neurol       Date:  1996-01       Impact factor: 3.372

2.  Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function.

Authors:  G A Lanza; A Dello Russo; V Giglio; L De Luca; L Messano; C Santini; E Ricci; A Damiani; G Fumagalli; G De Martino; F Mangiola; F Bellocci
Journal:  Am Heart J       Date:  2001-05       Impact factor: 4.749

3.  Decreased heart rate variability predicts death in amyotrophic lateral sclerosis.

Authors:  Susana Pinto; Anabela Pinto; Mamede De Carvalho
Journal:  Muscle Nerve       Date:  2012-09       Impact factor: 3.217

4.  Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy.

Authors:  Tamara O Thomas; Thomas M Morgan; William B Burnette; Larry W Markham
Journal:  Pediatr Cardiol       Date:  2012-03-21       Impact factor: 1.655

5.  Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R C Steinman; L M Rolnitzky; R E Kleiger; J N Rottman
Journal:  Am J Cardiol       Date:  1992-04-01       Impact factor: 2.778

6.  Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.

Authors:  John L Jefferies; Benjamin W Eidem; John W Belmont; William J Craigen; Stephanie M Ware; Susan D Fernbach; Steven R Neish; E O'brian Smith; Jeffrey A Towbin
Journal:  Circulation       Date:  2005-10-24       Impact factor: 29.690

Review 7.  Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?

Authors:  Melissa L Martin; Burns C Blaxall
Journal:  J Cardiovasc Transl Res       Date:  2012-09-27       Impact factor: 4.132

8.  Prognostic role of heart rate variability in patients with a recent acute myocardial infarction.

Authors:  G A Lanza; V Guido; M M Galeazzi; M Mustilli; R Natali; C Ierardi; C Milici; F Burzotta; V Pasceri; F Tomassini; A Lupi; A Maseri
Journal:  Am J Cardiol       Date:  1998-12-01       Impact factor: 2.778

9.  Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.

Authors:  Kan N Hor; Janaka Wansapura; Larry W Markham; Wojciech Mazur; Linda H Cripe; Robert Fleck; D Woodrow Benson; William M Gottliebson
Journal:  J Am Coll Cardiol       Date:  2009-04-07       Impact factor: 24.094

10.  Circadian rhythm and variability of heart rate in Duchenne-type progressive muscular dystrophy.

Authors:  M Yotsukura; K Sasaki; E Kachi; A Sasaki; T Ishihara; K Ishikawa
Journal:  Am J Cardiol       Date:  1995-11-01       Impact factor: 2.778

View more
  15 in total

1.  Central Arterial Function Measured by Non-invasive Pulse Wave Analysis is Abnormal in Patients with Duchenne Muscular Dystrophy.

Authors:  Thomas D Ryan; John J Parent; Zhiqian Gao; Philip R Khoury; Elizabeth Dupont; Jennifer N Smith; Brenda Wong; Elaine M Urbina; John L Jefferies
Journal:  Pediatr Cardiol       Date:  2017-06-21       Impact factor: 1.655

2.  Assessment of left ventricular dyssynchrony by speckle tracking echocardiography in children with duchenne muscular dystrophy.

Authors:  Alain Lacampagne; Pascal Amedro; Nicolas Lanot; Marie Vincenti; Hamouda Abassi; Charlene Bredy; Audrey Agullo; Lucie Gamon; Thibault Mura; Kathleen Lavastre; Gregoire De La Villeon; Catherine Barrea; Pierre Meyer; François Rivier; Albano C Meli; Jeremy Fauconnier; Olivier Cazorla
Journal:  Int J Cardiovasc Imaging       Date:  2021-12-14       Impact factor: 2.357

3.  Bone marrow mesenchymal stromal cells with CD47 high expression via the signal transducer and activators of transcription signaling pathway preventing myocardial fibrosis.

Authors:  Wei Deng; Qing-Wei Chen; Xing-Sheng Li; Zhong-Ming Yuan; Gui-Qiong Li; Da-Zhi Ke; Li Wang; Zhi-Qing Wu; Shi-Lan Luo
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 4.  Cardiac involvement in Duchenne and Becker muscular dystrophy.

Authors:  Sophie Mavrogeni; George Markousis-Mavrogenis; Antigoni Papavasiliou; Genovefa Kolovou
Journal:  World J Cardiol       Date:  2015-07-26

Review 5.  Heart Rate Variability and Cardiopulmonary Dysfunction in Patients with Duchenne Muscular Dystrophy: A Systematic Review.

Authors:  Talita Dias da Silva; Thais Massetti; Tânia Brusque Crocetta; Carlos Bandeira de Mello Monteiro; Alex Carll; Luiz Carlos Marques Vanderlei; Carlie Arbaugh; Fernando Rocha Oliveira; Luiz Carlos de Abreu; Celso Ferreira Filho; John Godleski; Celso Ferreira
Journal:  Pediatr Cardiol       Date:  2018-04-25       Impact factor: 1.655

Review 6.  Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.

Authors:  Sophie I Mavrogeni; Petros P Sfikakis; Theodoros Dimitroulas; Loukia Koutsogeorgopoulou; George Markousis-Mavrogenis; George Poulos; Genovefa Kolovou; George Theodorakis; George D Kitas
Journal:  Rheumatol Int       Date:  2018-07-24       Impact factor: 2.631

7.  Autonomic Modulation in Duchenne Muscular Dystrophy during a Computer Task: A Prospective Control Trial.

Authors:  Mayra Priscila Boscolo Alvarez; Talita Dias da Silva; Francis Meire Favero; Vitor Engrácia Valenti; Rodrigo Daminello Raimundo; Luiz Carlos Marques Vanderlei; David M Garner; Carlos Bandeira de Mello Monteiro
Journal:  PLoS One       Date:  2017-01-24       Impact factor: 3.240

8.  The evolution of electrocardiographic changes in patients with Duchenne muscular dystrophies.

Authors:  Woo Hyun Yoo; Min-Jung Cho; Peter Chun; Kwang Hun Kim; Je Sang Lee; Yong Beom Shin
Journal:  Korean J Pediatr       Date:  2017-06-22

9.  Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy.

Authors:  Min J Kim; Kenneth L Bible; Michael Regnier; Marvin E Adams; Stanley C Froehner; Nicholas P Whitehead
Journal:  Physiol Rep       Date:  2019-03

10.  Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial.

Authors:  Michael Taylor; John Jefferies; Barry Byrne; Joao Lima; Bharath Ambale-Venkatesh; Mohammad R Ostovaneh; Raj Makkar; Bryan Goldstein; Rachel Ruckdeschel Smith; James Fudge; Konstantinos Malliaras; Brian Fedor; Jeff Rudy; Janice M Pogoda; Linda Marbán; Deborah D Ascheim; Eduardo Marbán; Ronald G Victor
Journal:  Neurology       Date:  2019-01-23       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.